DLB DLB
Company Profile ↓Company Overview
DLB (DLB) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Maintains a net profit margin of 18.9%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $1.35B (+5.9% YoY); net profit $255.02M.
- Trailing 12 Months Year-on-year growth — revenue +5.9%, earnings -2.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.5%, profit CAGR 1.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 4.48% |
| 1 Year: | 5.92% |
Compounded Profit Growth
| 5 Years: | 1.46% |
| 1 Year: | -2.60% |
Stock Price Performance
| 1 Year: | -13.37% |
| 6 Months: | +1.67% |
| 3 Months: | +4.58% |
| 1 Month: | +24.44% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)77.06 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
- RSI at 77 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Jan 2016 | Apr 2016 | Jul 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Apr 2022 | Jul 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 299.53M | 299.72M | 214.78M | 240.57M | 302.38M | 338.26M | 302.16M | 298.83M | 291.88M | 351.81M | 246.91M | - | 389.87M | 319.56M | 286.80M | 351.63M | 334.37M | 289.58M | 334.92M | 375.89M | 298.37M | 315.57M | 364.52M | 288.82M | 357.00M | 369.56M | 315.55M | 307.02M | 346.71M | 395.63M | 305.00M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44.00M | 39.52M | 43.21M | 44.73M | 40.32M |
| Gross Profit | 207.37M | 211.05M | 249.97M | 252.97M | 202.78M | 236.30M | 240.50M | 273.54M | 212.81M | 268.63M | 268.69M | 180.40M | 209.31M | 263.75M | 301.68M | 262.47M | 252.87M | 254.56M | 314.99M | 217.02M | 228.73M | 354.57M | 287.18M | 255.16M | 318.92M | 298.86M | 253.63M | 300.47M | 334.84M | 256.86M | 283.51M | 325.75M | 253.16M | 316.23M | 333.72M | 271.54M | 267.50M | 303.50M | 350.90M | 264.68M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 224.45M | 231.70M | 230.87M | 235.77M | 226.41M |
| Operating Income | - | 39.19M | 82.33M | 81.19M | - | 66.07M | 63.28M | 95.93M | - | 93.95M | 84.60M | -7.61M | - | 68.67M | 102.93M | 34.26M | - | 48.59M | 105.94M | 34.14M | - | 164.75M | 83.19M | 56.09M | 90.58M | 43.35M | 45.57M | 94.09M | 109.22M | 15.94M | 66.22M | 108.97M | 36.78M | 79.88M | 107.76M | 47.09M | 35.80M | 72.63M | 115.13M | 38.27M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.49M | 60.38M | 99.44M | 141.98M | 63.34M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.52M | 41.67M | 71.60M | 119.70M | 43.80M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.97M | -7.99M | 17.92M | 24.25M | 14.59M |
| Net Income | 46.55M | 30.90M | 67.40M | 63.63M | 23.93M | 53.37M | 50.59M | 76.04M | 21.80M | -53.30M | 65.22M | 3.12M | 26.72M | 98.22M | 73.44M | 39.57M | 43.92M | 48.75M | 88.50M | 67.28M | 26.83M | 135.20M | 76.22M | 54.62M | 80.01M | 36.72M | 39.60M | 79.38M | 95.70M | 16.40M | 66.98M | 97.83M | 38.44M | 67.82M | 91.79M | 46.07M | 49.33M | 53.33M | 94.92M | 28.60M |
| Diluted EPS | 0.45 | 0.30 | 0.66 | 0.62 | 0.23 | 0.51 | 0.49 | 0.73 | 0.21 | -0.52 | 0.61 | 0.03 | 0.25 | 0.93 | 0.70 | 0.38 | 0.43 | 0.47 | 0.86 | 0.66 | 0.26 | 1.30 | 0.73 | 0.52 | 0.77 | 0.36 | 0.39 | 0.82 | 0.98 | 0.17 | 0.69 | 1.01 | 0.40 | 0.70 | 0.94 | 0.48 | 0.51 | 0.55 | 0.99 | 0.30 |
| R&D Expense | - | 53.33M | 52.09M | 54.98M | - | 57.52M | 58.34M | 59.63M | - | 56.44M | 59.49M | 60.36M | - | 58.65M | 58.62M | 60.41M | - | 57.65M | 60.09M | 59.58M | - | 63.77M | 65.81M | 62.09M | 68.82M | 67.42M | 62.86M | 64.45M | 67.95M | 68.70M | 67.03M | 62.49M | 65.50M | 66.64M | 61.71M | 65.98M | - | 69.08M | 63.65M | 65.75M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 640.23M | 719.50M | 922.71M | 961.07M | 933.01M | 909.67M | 960.18M | 970.64M | 1.03B | 1.08B | 1.05B | 1.24B | 1.16B | 1.28B | 1.25B | 1.30B | 1.27B | 1.35B |
| Gross Profit | 572.45M | 654.74M | 790.90M | 849.89M | 840.99M | 812.96M | 890.00M | 875.82M | 916.76M | 961.65M | 927.04M | 1.08B | 1.02B | 1.15B | 1.11B | 1.15B | 1.13B | 1.19B |
| Operating Income | 286.78M | 363.67M | 429.38M | 429.73M | 361.99M | 245.26M | 273.72M | 213.23M | 231.79M | 247.13M | 183.50M | 257.08M | 218.74M | 344.39M | 206.60M | 215.75M | 258.33M | 264.96M |
| Net Income | 199.46M | 242.99M | 283.45M | 309.27M | 264.30M | 189.27M | 206.10M | 181.39M | 185.86M | 206.48M | 41.75M | 255.15M | 231.36M | 310.23M | 184.09M | 200.66M | 261.82M | 255.02M |
| Diluted EPS | 1.74 | 2.11 | 2.46 | 2.75 | 2.46 | 1.84 | 1.99 | 1.75 | 1.81 | 2.00 | 0.39 | 2.44 | 2.25 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 |
| R&D Expense | 77.50M | 81.54M | 104.98M | 123.92M | 140.14M | 168.75M | 183.13M | 201.32M | 219.61M | 233.31M | 236.79M | 237.87M | 239.04M | 253.64M | 261.17M | 271.52M | 263.66M | 261.79M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.58B | 1.71B | 1.88B | 1.96B | 1.74B | 1.98B | 2.13B | 2.31B | 2.53B | 2.87B | 2.82B | 2.92B | 3.11B | 2.69B | 2.98B | 3.11B | 3.23B |
| Total Equity | 819.43M | 1.07B | 1.34B | 1.47B | 1.66B | 1.72B | 1.48B | 1.71B | 1.81B | 1.97B | 2.14B | 2.36B | 2.31B | 2.43B | 2.60B | 2.25B | 2.36B | 2.48B | 2.62B |
| Cash & Equivalents | 368.47M | 394.76M | 451.68M | 545.86M | 551.51M | 492.60M | 454.40M | 568.47M | 531.93M | 519.76M | 634.37M | 918.06M | 797.21M | 1.07B | 1.23B | 620.13M | 745.36M | 482.05M | 701.89M |
| Total Liabilities | - | - | 218.21M | 217.09M | 199.04M | 217.56M | 237.92M | 252.36M | 317.29M | 331.37M | 389.71M | 494.88M | 508.72M | 478.92M | 501.45M | 438.53M | 607.58M | 623.03M | 595.81M |
| Current Liabilities | - | - | 156.58M | 165.76M | 159.38M | 156.84M | 172.81M | 189.37M | 209.68M | 213.08M | 245.77M | 285.20M | 306.85M | 267.11M | 315.72M | 277.52M | 422.23M | 417.84M | 437.79M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 264.47M | 273.23M | 327.30M | 403.69M | 389.92M | 276.50M | 361.55M | 309.38M | 360.06M | 377.79M | 352.20M | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M | 327.25M | 472.20M |
| Investing Cash Flow | -271.34M | -236.50M | -44.36M | -236.70M | -194.80M | 175.03M | -204.94M | -203.59M | -282.50M | -158.03M | 78.09M | -56.23M | 134.37M | -44.91M | -295.94M | 54.21M | -286.29M | -10.59M |
| Financing Cash Flow | 34.90M | 21.52M | -184.77M | -162.50M | -254.32M | -487.96M | -40.58M | -138.52M | -91.99M | -106.83M | -133.63M | -385.28M | -207.78M | -252.51M | -610.56M | -236.81M | -287.81M | -247.24M |
| Capital Expenditure | -13.61M | -13.99M | -37.48M | -47.36M | -167.35M | -26.71M | -75.36M | -157.53M | -100.76M | -99.62M | -72.81M | -96.28M | -66.35M | -54.45M | -47.93M | -30.34M | -30.01M | -36.35M |
| Free Cash Flow | 250.86M | 259.23M | 289.82M | 356.33M | 222.57M | 249.79M | 286.18M | 151.85M | 259.30M | 278.18M | 279.39M | 231.39M | 277.50M | 393.30M | 270.65M | 336.74M | 297.25M | 435.85M |
| Share Buybacks | - | - | 241.36M | 192.41M | 268.20M | 82.25M | 56.03M | 107.35M | 100.85M | 100.00M | 150.47M | 340.58M | 173.74M | 245.86M | 530.49M | 149.28M | 160.00M | 124.99M |
| Dividends Paid | - | - | - | 0 | 0 | 408.21M | 0 | 41.02M | 48.40M | 57.06M | 66.16M | 77.50M | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 89.4% | 91.0% | 85.7% | 88.4% | 90.1% | 89.4% | 92.7% | 90.2% | 89.4% | 89.0% | 87.9% | 87.0% | 87.4% | 89.9% | 88.7% | 88.3% | 89.0% | 88.1% |
| Operating Margin % | 44.8% | 50.5% | 46.5% | 44.7% | 38.8% | 27.0% | 28.5% | 22.0% | 22.6% | 22.9% | 17.4% | 20.7% | 18.8% | 26.9% | 16.5% | 16.6% | 20.3% | 19.6% |
| Net Margin % | 31.2% | 33.8% | 30.7% | 32.2% | 28.3% | 20.8% | 21.5% | 18.7% | 18.1% | 19.1% | 4.0% | 20.5% | 19.9% | 24.2% | 14.7% | 15.4% | 20.6% | 18.9% |
| ROE % | 18.6% | 18.1% | 19.2% | 18.6% | 15.4% | 12.8% | 12.1% | 10.0% | 9.4% | 9.7% | 1.8% | 11.1% | 9.5% | 11.9% | 8.2% | 8.5% | 10.6% | 9.7% |
| ROCE % | - | 25.5% | 27.8% | 24.9% | 20.1% | 15.7% | 15.3% | 11.1% | 11.1% | 10.8% | 7.1% | 10.2% | 8.3% | 12.3% | 8.6% | 8.4% | 9.6% | 9.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DLB
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?
Dolby targets a sharp fiscal Q4 rebound as content deals, auto Atmos growth and licensing gains face contract-timing volatility.
Is Dolby Stock Worth Buying as Growth Meets Near-Term Execution Risks?
Dolby's discounted valuation and $756 million cash balance support its long-term case as premium formats and auto licensing expand.
Does Dolby Laboratories (DLB) Look Fairly Valued After Q3 Results?
Dolby Laboratories has just enjoyed a sharp rebound, yet after a share price that is still down over the past several years, the current valuation checks point to a stock that screens closer to cheap than expensive rather than obviously mis…
Dolby Laboratories (DLB) Is Up 18.0% After Raising Buybacks And Guidance – Has The Bull Case Changed?
In late July 2026, Dolby Laboratories reported third-quarter revenue of US$305 million and net income of US$28.6 million, paired with new fourth-quarter and full-year 2026 guidance, a US$0.36 dividend declaration, and an expanded share repu…
DLB Q2 Deep Dive: Patent Licensing and Automotive Momentum Offset Softer Device Sales
Audio and video technology company Dolby Laboratories (NYSE:DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations w…
InterDigital Is Riding AI Streaming and IoT Licensing Growth Trends
IDCC is expanding beyond smartphones with AI, streaming and IoT licensing, opening new royalty opportunities across fast-growing technology markets.
DLB — Frequently Asked Questions
What is the current share price of DLB?
As of 2026-08-05 17:25 PDT, DLB trades at $61.36 on NASDAQ/NYSE. Its 52-week range is $48.51 to $74.34.
What is the P/E ratio of DLB?
DLB trades at a trailing price-to-earnings (P/E) ratio of 23.42.
What is the return on equity (ROE) of DLB?
DLB has a return on equity (ROE) of 9.72%. Its return on capital employed (ROCE) is 9.50%.
Is DLB a good stock to buy?
This page provides a data-driven analysis of DLB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.